Dragon Pharma Livagen

IDENTITYCompoundLivagen
CategoryPeptide Bioregulator
Strength20 mg/vial
FormLyophilized Powder
ClassResearch Peptide

PEPTIDE PROFILEAdministrationSC / IM (after reconstitution)
ReconstitutionBacteriostatic Water
ActionCellular Bioregulation
TargetLiver Tissue
Clinical UseResearch & Organ Support

PHARMACOLOGYMechanismGene Expression Modulation
Protein SynthesisSupports Cellular Function
MetabolismPeptide Degradation
AdministrationParenteral
Hormonal EffectNone Direct

STORAGE & RECONSTITUTIONBrandDragon Pharma
Package20 mg Lyophilized Vial
Storage2–8°C
After MixingRefrigerate 2–8°C
DiluentBacteriostatic Water

ADMINISTRATIONTypical Dose5–20 mg/day
FrequencyOnce Daily
RouteSC or IM
Course10–30 days
ReconstitutionBefore First Use

USAGE PROFILEBeginner5 mg/day
Intermediate10 mg/day
Advanced20 mg/day
Typical Course2–4 weeks
Repeat CycleAfter 1–2 months

BODYBUILDING USAGEOff-SeasonRecovery Support
Contest PrepLiver Support
During CycleCommonly Used
PCTSupportive Only
GoalHepatic Recovery

COMPATIBILITYWith AASCompatible
With GHCompatible
With PeptidesCompatible
With PCTSupportive
Stack RoleOrgan Support

MECHANISM OF ACTIONPrimary TargetHepatocytes
Cell EffectProtein Regulation
DNA ActivityGene Expression
RecoveryCellular Repair Support
OutcomeTissue Homeostasis

PHARMACOKINETICSAbsorptionRapid After Injection
DistributionSystemic
MetabolismProteolytic Enzymes
EliminationPeptide Catabolism
AccumulationNot Expected

SAFETY PROFILELiver ToxicityNot Known
Kidney ToxicityLow
Hormonal EffectNone Direct
HPTA SuppressionNo
PCT NeededNo

CHEMICAL PROFILECompoundLivagen
TypeShort Peptide
OriginBioregulator
AdministrationInjectable
StatusResearch Compound

OVERVIEW

Livagen is a peptide bioregulator investigated for its potential role in supporting normal liver cellular activity through modulation of gene expression and protein synthesis. Within bodybuilding communities it is commonly discussed as a supportive compound during prolonged performance-enhancing drug protocols where maintaining hepatic function is considered an important aspect of overall health monitoring.

BENEFITS

Supports normal liver cell function
May assist recovery after intensive cycles
Compatible with most performance protocols
Non-hormonal mechanism
No direct anabolic activity
Suitable for organ support strategies
Simple once-daily administration

POTENTIAL RISKS

Injection-site irritation
Possible hypersensitivity reactions
Limited long-term human data
Use sterile reconstitution technique
Not intended during pregnancy
Avoid contaminated solutions
Medical supervision recommended

PERFORMANCE PROFILE

Liver Support

95%

Recovery Support

88%

Cycle Compatibility

92%

Muscle Gain

Hormonal Suppression

WHAT IS DRAGON PHARMA?

Dragon Pharma is an international pharmaceutical manufacturer recognized within the performance-enhancement community for producing injectable and oral compounds, peptides, ancillary medications and hormone-related products under standardized manufacturing procedures. The company's product portfolio includes anabolic steroids, peptide formulations, hormone support medications and research compounds distributed across numerous international markets.

Dragon Pharma products are manufactured with an emphasis on pharmaceutical-grade raw materials, batch consistency, sterile production processes for injectable products and quality-control testing designed to maintain product identity, concentration and stability throughout shelf life.

WHY CHOOSE DRAGON PHARMA

Pharmaceutical-style manufacturing standards.
Consistent peptide concentration between production batches.
Sterile lyophilized peptide manufacturing.
Tamper-resistant product verification systems on supported products.
Broad portfolio covering peptides, hormones and ancillary medications.
Recognized international brand among performance-enhancement users.
Long-established reputation for manufacturing consistency.

CONCLUSION

Dragon Pharma Livagen 20 mg is a peptide bioregulator supplied as a lyophilized powder requiring reconstitution before administration. Unlike anabolic steroids or peptide hormones, Livagen is investigated for its potential influence on liver cellular regulation rather than direct endocrine stimulation.

Among bodybuilding users, Livagen is generally incorporated as a supportive compound during extended anabolic steroid cycles, post-cycle recovery periods, or intensive training phases where preservation of normal hepatic function is considered important. It is not intended to increase muscle mass or strength directly but may complement comprehensive health-support strategies.

Because published clinical evidence remains limited, Livagen should be regarded as an investigational peptide. Proper laboratory monitoring, sterile injection technique, appropriate storage after reconstitution, and evidence-based medical guidance remain essential whenever peptide-based products are used.

DISCLAIMER

This information is provided exclusively for educational purposes. Livagen is an investigational peptide bioregulator and should not be interpreted as an approved treatment for disease or as a recommendation for non-medical performance enhancement. Bodybuilding applications discussed represent community practices rather than approved medical indications. Individuals should consult qualified healthcare professionals regarding diagnosis, treatment and applicable regulations.